ID: ALA4783104

Max Phase: Preclinical

Molecular Formula: C45H57N11O9

Molecular Weight: 896.02

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(N)=O

Standard InChI:  InChI=1S/C45H57N11O9/c1-24(57)39(40(49)60)56-45(65)35(18-25-13-15-28(58)16-14-25)54-42(62)34(12-6-7-17-46)52-43(63)37(20-27-23-51-33-11-5-3-9-30(27)33)55-44(64)36(53-41(61)31(47)21-38(48)59)19-26-22-50-32-10-4-2-8-29(26)32/h2-5,8-11,13-16,22-24,31,34-37,39,50-51,57-58H,6-7,12,17-21,46-47H2,1H3,(H2,48,59)(H2,49,60)(H,52,63)(H,53,61)(H,54,62)(H,55,64)(H,56,65)/t24-,31+,34+,35+,36+,37+,39+/m1/s1

Standard InChI Key:  QYXABJILOMKVOP-PMPNJECKSA-N

Associated Targets(Human)

Urotensin II receptor 1388 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 896.02Molecular Weight (Monoisotopic): 895.4341AlogP: -1.00#Rotatable Bonds: 24
Polar Surface Area: 355.76Molecular Species: BASEHBA: 11HBD: 13
#RO5 Violations: 3HBA (Lipinski): 20HBD (Lipinski): 17#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.42CX Basic pKa: 10.19CX LogP: -2.26CX LogD: -4.05
Aromatic Rings: 5Heavy Atoms: 65QED Weighted: 0.03Np Likeness Score: 0.22

References

1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C.  (2016)  Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist.,  59  (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164]

Source